110 related articles for article (PubMed ID: 32509187)
1. Methylation and serum response factor mediated in the regulation of gene ARRDC3 in breast cancer.
Lin S; Zhang G; Zhao Y; Shi D; Ye Q; Li Y; Wang S
Am J Transl Res; 2020; 12(5):1913-1927. PubMed ID: 32509187
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
Wang D; Yang PN; Chen J; Zhou XY; Liu QJ; Li HJ; Li CL
Mol Cell Biochem; 2014 Nov; 396(1-2):67-77. PubMed ID: 25148870
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation assay of SASH1 gene in breast cancer.
Sheyu L; Hui L; Junyu Z; Jiawei X; Honglian W; Qing S; Hengwei Z; Xuhui G; Qinghe X; Lin H
J BUON; 2013; 18(4):891-8. PubMed ID: 24344014
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
[TBL] [Abstract][Full Text] [Related]
7. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
8. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
9. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
11. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway.
Jiao XX; Lin SY; Lian SX; Qiu YR; Li ZH; Chen ZH; Lu WQ; Zhang Y; Deng L; Jiang Y; Hu GH
Neoplasma; 2020 Jul; 67(4):834-842. PubMed ID: 32386478
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer.
Kuznetsova EB; Kekeeva TV; Larin SS; Zemlyakova VV; Khomyakova AV; Babenko OV; Nemtsova MV; Zaletayev DV; Strelnikov VV
J Carcinog; 2007 May; 6():9. PubMed ID: 17477881
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.
Kusui C; Kimura T; Ogita K; Nakamura H; Matsumura Y; Koyama M; Azuma C; Murata Y
Biochem Biophys Res Commun; 2001 Dec; 289(3):681-6. PubMed ID: 11726201
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation assay of SASH1 gene in hepatocellular carcinoma.
Peng L; Wei H; Liren L
J BUON; 2014; 19(4):1041-7. PubMed ID: 25536614
[TBL] [Abstract][Full Text] [Related]
16. Selective Inhibitors of Nuclear Export (SINE) compounds block proliferation and migration of triple negative breast cancer cells by restoring expression of ARRDC3.
Soung YH; Kashyap T; Nguyen T; Yadav G; Chang H; Landesman Y; Chung J
Oncotarget; 2017 Aug; 8(32):52935-52947. PubMed ID: 28881784
[TBL] [Abstract][Full Text] [Related]
17. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K
Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
[TBL] [Abstract][Full Text] [Related]
20. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression.
Deng G; Chen A; Pong E; Kim YS
Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]